Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.31 +0.01 (+3.33%)
At close: Sep 30, 2026 · 4:00 PM EDT

Vistagen Therapeutics (VTGN) Total Non-Current Liabilities (2011 - 2023)

Updated

Vistagen Therapeutics (VTGN) reported Total Non-Current Liabilities of $3.64 million for fiscal Q2 2024 (quarter ended Sep 30, 2023), down 27.9% from $5.05 million a year earlier and down 11.9% from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Total Non-Current Liabilities (2011 - 2023) Analysis & Trends

At the end of FY2023 (ended Mar 31, 2023), Vistagen Therapeutics posted Total Non-Current Liabilities of $4.44 million, up 6.7% from FY2022.

  • Total Non-Current Liabilities has a five-year compound annual growth rate of 8.9% (FY2018 to FY2023).
  • By fiscal year, Total Non-Current Liabilities came in at $4.16 million in FY2022 (-65.6%), $12.11 million in FY2021 (+38.8%), $8.73 million in FY2020 (+111.1%) and $4.14 million in FY2019 (+42.4%).
  • The fiscal Q2 2024 figure ranks as the lowest quarterly Total Non-Current Liabilities since fiscal Q2 2019.
  • Year over year, Total Non-Current Liabilities gained in three of the last eight quarters, with an average decline of 31.9%.
  • The high point for year-over-year Total Non-Current Liabilities in five years was fiscal Q1 2020 (growth of 153.4%); the low point was fiscal Q1 2023 (a decline of 68.8%).
  • Per Business Quant data, the three fiscal quarters before Q2 2024 came in at $4.13 million (Q1 2024), $4.44 million (Q4 2023) and $4.75 million (Q3 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Vistagen Therapeutics 13.76 Mn 13.76 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 3.64 Mn
Jun 30, 2023 4.13 Mn
Mar 31, 2023 4.44 Mn
Dec 31, 2022 4.75 Mn
Sep 30, 2022 5.05 Mn
Jun 30, 2022 3.75 Mn
Mar 31, 2022 4.16 Mn
Dec 31, 2021 4.14 Mn
Sep 30, 2021 11.93 Mn
Jun 30, 2021 12.02 Mn
Mar 31, 2021 12.11 Mn
Dec 31, 2020 12.48 Mn
Sep 30, 2020 12.75 Mn
Jun 30, 2020 9.11 Mn
Mar 31, 2020 8.73 Mn
Dec 31, 2019 8.49 Mn
Sep 30, 2019 8.25 Mn
Jun 30, 2019 8.01 Mn
Mar 31, 2019 4.14 Mn
Dec 31, 2018 3.86 Mn
API Access

Vistagen Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=VTGN&period=max&api_key=YOUR_API_KEY